{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T21:07:28Z","timestamp":1765487248302,"version":"3.44.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04212-3","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T04:00:34Z","timestamp":1755316834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of alpha-1 acid glycoprotein with hepatic steatosis and liver fibrosis among women: a population-based study"],"prefix":"10.1186","volume":"25","author":[{"given":"Sichang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"issue":"1","key":"4212_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4212_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.857110","volume":"13","author":"R Xie","year":"2022","unstructured":"Xie R, Liu M. Relationship between non-alcoholic fatty liver disease and degree of hepatic steatosis and bone mineral density. Front Endocrinol (Lausanne). 2022;13: 857110.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"4212_CR3","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467\u201374.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"4212_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/hep.31608","volume":"73","author":"MT Long","year":"2021","unstructured":"Long MT, Zhang X, Xu H, Liu CT, Corey KE, Chung RT, Loomba R, Benjamin EJ. Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: the Framingham heart study. Hepatology. 2021;73(2):548\u201359.","journal-title":"Hepatology"},{"issue":"4","key":"4212_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1053\/j.gastro.2023.06.030","volume":"165","author":"G Semmler","year":"2023","unstructured":"Semmler G, Yang Z, Fritz L, K\u00f6ck F, Hofer BS, Balcar L, Hartl L, Jachs M, Stopfer K, Schedlbauer A, et al. Dynamics in liver stiffness measurements predict outcomes in advanced chronic liver disease. Gastroenterology. 2023;165(4):1041\u201352.","journal-title":"Gastroenterology"},{"issue":"6","key":"4212_CR6","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, et al. Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717\u201330.","journal-title":"Gastroenterology"},{"issue":"12","key":"4212_CR7","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","volume":"29","author":"L Sandrin","year":"2003","unstructured":"Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705\u201313.","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"4212_CR8","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jhep.2010.07.033","volume":"54","author":"EA Tsochatzis","year":"2011","unstructured":"Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol. 2011;54(4):650\u20139.","journal-title":"J Hepatol"},{"issue":"6","key":"4212_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2174\/1389203720666190405101138","volume":"20","author":"F Ceciliani","year":"2019","unstructured":"Ceciliani F, Lecchi C. The immune functions of \u03b1(1) acid glycoprotein. Curr Protein Pept Sci. 2019;20(6):505\u201324.","journal-title":"Curr Protein Pept Sci"},{"issue":"1","key":"4212_CR10","doi-asserted-by":"publisher","first-page":"17329","DOI":"10.1038\/s41598-018-35339-x","volume":"8","author":"J Bi","year":"2018","unstructured":"Bi J, Watanabe H, Fujimura R, Nishida K, Nakamura R, Oshiro S, Imafuku T, Komori H, Miyahisa M, Tanaka M, et al. A downstream molecule of 1,25-dihydroxyvitamin D3, alpha-1-acid glycoprotein, protects against mouse model of renal fibrosis. Sci Rep. 2018;8(1):17329.","journal-title":"Sci Rep"},{"issue":"7","key":"4212_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5414\/CP201539","volume":"49","author":"K Hanada","year":"2011","unstructured":"Hanada K, Yamanaka E, Yamamoto N, Minami H, Kawai S, Sasaki Y, Ogata H. Effects of surgery and chronic disease states on the concentrations and phenotype distribution of \u03b11-acid glycoprotein: studies in patients with breast cancer and patients with chronic inflammatory disease. Int J Clin Pharmacol Ther. 2011;49(7):415\u201321.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"4212_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5009\/gnl19282","volume":"15","author":"DH Lim","year":"2021","unstructured":"Lim DH, Kim M, Jun DW, Kwak MJ, Yoon JH, Lee KN, Lee HL, Lee OY, Yoon BC, Choi HS, et al. Diagnostic performance of serum asialo \u03b1(1)-acid glycoprotein levels to predict liver cirrhosis. Gut Liver. 2021;15(1):109\u201316.","journal-title":"Gut Liver"},{"issue":"12","key":"4212_CR13","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1093\/clinchem\/48.12.2195","volume":"48","author":"I Ryd\u00e9n","year":"2002","unstructured":"Ryd\u00e9n I, P\u00e5hlsson P, Lindgren S. Diagnostic accuracy of alpha(1)-acid glycoprotein fucosylation for liver cirrhosis in patients undergoing hepatic biopsy. Clin Chem. 2002;48(12):2195\u2013201.","journal-title":"Clin Chem"},{"issue":"9","key":"4212_CR14","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1248\/cpb.40.2516","volume":"40","author":"N Sugihara","year":"1992","unstructured":"Sugihara N, Furuno K, Kita N, Murakami T, Yata N. Plasma alpha 1-acid glycoprotein concentration in rats with chemical liver injury. Chem Pharm Bull (Tokyo). 1992;40(9):2516\u20139.","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"2","key":"4212_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/039139889101400207","volume":"14","author":"MP Vasson","year":"1991","unstructured":"Vasson MP, Paul JL, Couderc R, Albuisson E, Bargnoux PJ, Baguet JC, Raichvarg D. Serum alpha-1 acid glycoprotein in chronic renal failure and hemodialysis. Int J Artif Organs. 1991;14(2):92\u20136.","journal-title":"Int J Artif Organs"},{"issue":"5","key":"4212_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2217\/bmm-2016-0284","volume":"11","author":"D Zhang","year":"2017","unstructured":"Zhang D, Huang J, Luo D, Feng X, Liu Y, Liu Y. Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis. Biomark Med. 2017;11(5):423\u201330.","journal-title":"Biomark Med"},{"issue":"5","key":"4212_CR17","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","volume":"61","author":"M Arrese","year":"2016","unstructured":"Arrese M, Cabrera D, Kalergis AM, Feldstein AE. Innate immunity and inflammation in NAFLD\/NASH. Dig Dis Sci. 2016;61(5):1294\u2013303.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"4212_CR18","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1210\/en.2006-0417","volume":"147","author":"MA den Boer","year":"2006","unstructured":"den Boer MA, Voshol PJ, Schr\u00f6der-van der Elst JP, Korsheninnikova E, Ouwens DM, Kuipers F, Havekes LM, Romijn JA. Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice. Endocrinology. 2006;147(10):4553\u20138.","journal-title":"Endocrinology"},{"issue":"6","key":"4212_CR19","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","volume":"44","author":"JW Haukeland","year":"2006","unstructured":"Haukeland JW, Dam\u00e5s JK, Konopski Z, L\u00f8berg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bj\u00f8ro K, Aukrust P. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol. 2006;44(6):1167\u201374.","journal-title":"J Hepatol"},{"issue":"7","key":"4212_CR20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s11695-010-0181-4","volume":"20","author":"F Rabelo","year":"2010","unstructured":"Rabelo F, Oliveira CP, Faintuch J, Mazo DF, Lima VM, Stefano JT, Barbeiro HV, Soriano FG, Alves VA, Carrilho FJ. Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis. Obes Surg. 2010;20(7):906\u201312.","journal-title":"Obes Surg"},{"issue":"155","key":"4212_CR21","first-page":"1","volume":"2","author":"LR Curtin","year":"2012","unstructured":"Curtin LR, Mohadjer LK, Dohrmann SM, Montaquila JM, Kruszan-Moran D, Mirel LB, Carroll MD, Hirsch R, Schober S, Johnson CL. The National Health and Nutrition Examination Survey: Sample Design, 1999\u20132006. Vital Health Stat 2. 2012;2(155):1\u201339.","journal-title":"Vital Health Stat 2"},{"issue":"12","key":"4212_CR22","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2105\/AJPH.2021.306517","volume":"111","author":"R Paulose-Ram","year":"2021","unstructured":"Paulose-Ram R, Graber JE, Woodwell D, Ahluwalia N. The national health and nutrition examination survey (NHANES), 2021\u20132022: adapting data collection in a COVID-19 environment. Am J Public Health. 2021;111(12):2149\u201356.","journal-title":"Am J Public Health"},{"issue":"2","key":"4212_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24225","volume":"36","author":"N Yang","year":"2022","unstructured":"Yang N, Lu Y, Cao L, Lu M. The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults. J Clin Lab Anal. 2022;36(2): e24225.","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"4212_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0168-8278(86)80083-6","volume":"2","author":"SetaN Serbource-Goguel","year":"1986","unstructured":"Serbource-Goguel Seta N, Durand G, Corbic M, Agneray J, Fegar J. Alterations in relative proportions of microheterogenous forms of human alpha 1-acid glycoprotein in liver disease. J Hepatol. 1986;2(2):245\u201352.","journal-title":"J Hepatol"},{"issue":"4","key":"4212_CR25","first-page":"589","volume":"69","author":"T Ozeki","year":"1988","unstructured":"Ozeki T, Imanishi K, Uchiyama T, Sanefuji H, Fujiwara H, Mizuno S, Tanaka N, Suzuki I. Alpha 1-acid glycoprotein and hepatic fibrosis. Br J Exp Pathol. 1988;69(4):589\u201395.","journal-title":"Br J Exp Pathol"},{"issue":"4","key":"4212_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3350\/cmh.2021.0127","volume":"27","author":"HY Kim","year":"2021","unstructured":"Kim HY. Recent advances in nonalcoholic fatty liver disease metabolomics. Clin Mol Hepatol. 2021;27(4):553\u20139.","journal-title":"Clin Mol Hepatol"},{"issue":"45","key":"4212_CR27","doi-asserted-by":"publisher","first-page":"7739","DOI":"10.3748\/wjg.v27.i45.7739","volume":"27","author":"GO Elpek","year":"2021","unstructured":"Elpek GO. Orosomucoid in liver diseases. World J Gastroenterol. 2021;27(45):7739\u201347.","journal-title":"World J Gastroenterol"},{"issue":"1\u20132","key":"4212_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0167-4838(00)00153-9","volume":"1482","author":"T Fournier","year":"2000","unstructured":"Fournier T, Medjoubi NN, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta. 2000;1482(1\u20132):157\u201371.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"4212_CR29","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134(6):1655\u201369.","journal-title":"Gastroenterology"},{"issue":"4","key":"4212_CR30","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1365-2125.1984.tb02525.x","volume":"18","author":"J Barre","year":"1984","unstructured":"Barre J, Houin G, Rosenbaum J, Zini R, Dhumeaux D, Tillement JP. Decreased alpha 1-acid glycoprotein in liver cirrhosis: consequences for drug protein binding. Br J Clin Pharmacol. 1984;18(4):652\u20133.","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"4212_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22(7):429\u201343.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"4212_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster S, Cabrera D, Arrese M, Feldstein AE. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. 2018;15(6):349\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"4212_CR33","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.cgh.2019.01.027","volume":"17","author":"S Pelusi","year":"2019","unstructured":"Pelusi S, Cespiati A, Rametta R, Pennisi G, Mannisto V, Rosso C, Baselli G, Dongiovanni P, Fracanzani AL, Badiali S, et al. Prevalence and risk factors of significant fibrosis in patients with nonalcoholic fatty liver without steatohepatitis. Clin Gastroenterol Hepatol. 2019;17(11):2310\u2013e23192316.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"4212_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"4","key":"4212_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jhep.2022.11.029","volume":"78","author":"AJ Sanyal","year":"2023","unstructured":"Sanyal AJ, Williams SA, Lavine JE, Neuschwander-Tetri BA, Alexander L, Ostroff R, Biegel H, Kowdley KV, Chalasani N, Dasarathy S, et al. Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease. J Hepatol. 2023;78(4):693\u2013703.","journal-title":"J Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04212-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04212-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04212-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T14:46:53Z","timestamp":1757429213000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04212-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4212"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04212-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"type":"electronic","value":"1471-230X"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All aspects of this study involving human participants, biological samples, or human data were conducted in accordance with the Declaration of Helsinki and received approval from the NCHS Ethics Review Board. Written informed consent was obtained from all participants prior to their inclusion in this study. Furthermore, the NHANES data used in this analysis are fully de-identified and publicly accessible, thereby safeguarding participant confidentiality while facilitating transparent and reproducible research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"587"}}